Calumet Specialty Products Partners (CLMT) - Net Assets
Based on the latest financial reports, Calumet Specialty Products Partners (CLMT) has net assets worth $-449.70 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.73 Billion) and total liabilities ($3.18 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CLMT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-449.70 Million |
| % of Total Assets | -16.45% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -177.21% |
| Growth Volatility | 280.87 |
Calumet Specialty Products Partners - Net Assets Trend (2001–2024)
This chart illustrates how Calumet Specialty Products Partners's net assets have evolved over time, based on quarterly financial data. Also explore Calumet Specialty Products Partners asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Calumet Specialty Products Partners (2001–2024)
The table below shows the annual net assets of Calumet Specialty Products Partners from 2001 to 2024. For live valuation and market cap data, see CLMT market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-466.30 Million | -90.56% |
| 2023-12-31 | $-244.70 Million | +14.95% |
| 2022-12-31 | $-287.70 Million | +25.29% |
| 2021-12-31 | $-385.10 Million | -199.46% |
| 2020-12-31 | $-128.60 Million | -695.37% |
| 2019-12-31 | $21.60 Million | -67.12% |
| 2018-12-31 | $65.70 Million | -45.20% |
| 2017-12-31 | $119.90 Million | -45.18% |
| 2016-12-31 | $218.70 Million | -63.79% |
| 2015-12-31 | $603.90 Million | -25.46% |
| 2014-12-31 | $810.20 Million | -23.77% |
| 2013-12-31 | $1.06 Billion | +19.44% |
| 2012-12-31 | $889.79 Million | +22.07% |
| 2011-12-31 | $728.90 Million | +83.01% |
| 2010-12-31 | $398.28 Million | -17.94% |
| 2009-12-31 | $485.35 Million | +2.56% |
| 2008-12-31 | $473.21 Million | +18.41% |
| 2007-12-31 | $399.64 Million | +5.53% |
| 2006-12-31 | $378.69 Million | +869.64% |
| 2005-12-31 | $39.05 Million | +13.15% |
| 2004-12-31 | $34.51 Million | -- |
| 2003-12-31 | $0.00 | -- |
| 2002-12-31 | $0.00 | -- |
| 2001-12-31 | $0.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Calumet Specialty Products Partners's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 153900000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $900.00K | % |
| Other Comprehensive Income | $800.00K | % |
| Other Components | $824.50 Million | % |
| Total Equity | $-712.80 Million | 100.00% |
Calumet Specialty Products Partners Competitors by Market Cap
The table below lists competitors of Calumet Specialty Products Partners ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DXP Enterprises Inc
NASDAQ:DXPE
|
$2.23 Billion |
|
SAGILITY INDIA LIMITED
NSE:SAGILITY
|
$2.24 Billion |
|
Melexis NV
BR:MELE
|
$2.24 Billion |
|
Roshow Technology Co Ltd
SHE:002617
|
$2.24 Billion |
|
Turpaz Industries Ltd
TA:TRPZ
|
$2.23 Billion |
|
Kaiser Aluminum Corporation
NASDAQ:KALU
|
$2.23 Billion |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
|
$2.23 Billion |
|
Inv La Constru
SN:ILC
|
$2.23 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Calumet Specialty Products Partners's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -491,600,000 to -712,800,000, a change of -221,200,000.
- Net loss of 222,000,000 reduced equity.
- Other comprehensive income increased equity by 8,000,000.
- Other factors decreased equity by 7,200,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-222.00 Million | -31.14% |
| Other Comprehensive Income | $8.00 Million | +1.12% |
| Other Changes | $-7.20 Million | -1.01% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Calumet Specialty Products Partners's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $17362.00 | $32.08 | x |
| 2003-12-31 | $25544.00 | $32.08 | x |
| 2004-12-31 | $1.37 | $32.08 | x |
| 2005-12-31 | $1.55 | $32.08 | x |
| 2006-12-31 | $13.17 | $32.08 | x |
| 2007-12-31 | $13.90 | $32.08 | x |
| 2008-12-31 | $14.68 | $32.08 | x |
| 2009-12-31 | $14.99 | $32.08 | x |
| 2010-12-31 | $11.27 | $32.08 | x |
| 2011-12-31 | $17.09 | $32.08 | x |
| 2012-12-31 | $15.98 | $32.08 | x |
| 2013-12-31 | $15.64 | $32.08 | x |
| 2014-12-31 | $11.63 | $32.08 | x |
| 2015-12-31 | $8.06 | $32.08 | x |
| 2016-12-31 | $2.84 | $32.08 | x |
| 2017-12-31 | $1.55 | $32.08 | x |
| 2018-12-31 | $-0.11 | $32.08 | x |
| 2019-12-31 | $0.12 | $32.08 | x |
| 2020-12-31 | $-1.76 | $32.08 | x |
| 2021-12-31 | $-4.92 | $32.08 | x |
| 2022-12-31 | $-6.73 | $32.08 | x |
| 2023-12-31 | $-6.14 | $32.08 | x |
| 2024-12-31 | $-8.57 | $32.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Calumet Specialty Products Partners utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.30%
- • Asset Turnover: 1.52x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-28.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -76.51% | -4.33% | 1.76x | 10.07x | $-15.02 Million |
| 2003 | -19.30% | -1.15% | 2.27x | 7.42x | $-7.49 Million |
| 2004 | 25.99% | 1.66% | 1.70x | 9.22x | $5.52 Million |
| 2005 | 29.01% | 0.88% | 3.22x | 10.23x | $7.42 Million |
| 2006 | 24.79% | 5.72% | 3.10x | 1.40x | $56.01 Million |
| 2007 | 20.74% | 5.06% | 2.41x | 1.70x | $42.91 Million |
| 2008 | 9.39% | 1.79% | 2.30x | 2.28x | $-2.88 Million |
| 2009 | 12.48% | 3.28% | 1.79x | 2.13x | $12.01 Million |
| 2010 | 4.11% | 0.75% | 2.15x | 2.55x | $-23.46 Million |
| 2011 | 11.81% | 2.75% | 1.81x | 2.38x | $13.18 Million |
| 2012 | 22.99% | 4.39% | 2.07x | 2.53x | $115.56 Million |
| 2013 | 0.31% | 0.06% | 2.02x | 2.53x | $-102.98 Million |
| 2014 | -13.85% | -1.94% | 1.86x | 3.85x | $-193.22 Million |
| 2015 | -23.08% | -3.31% | 1.43x | 4.88x | $-199.79 Million |
| 2016 | -150.25% | -9.13% | 1.32x | 12.46x | $-350.47 Million |
| 2017 | -86.57% | -2.76% | 1.40x | 22.43x | $-115.79 Million |
| 2018 | 0.00% | -1.58% | 1.68x | 0.00x | $-54.23 Million |
| 2019 | -454.17% | -1.26% | 1.86x | 193.52x | $-44.56 Million |
| 2020 | 0.00% | -6.57% | 1.25x | 0.00x | $-135.24 Million |
| 2021 | 0.00% | -8.10% | 1.48x | 0.00x | $-216.01 Million |
| 2022 | 0.00% | -3.62% | 1.71x | 0.00x | $-116.44 Million |
| 2023 | 0.00% | 1.15% | 1.52x | 0.00x | $97.26 Million |
| 2024 | 0.00% | -5.30% | 1.52x | 0.00x | $-150.72 Million |
Industry Comparison
This section compares Calumet Specialty Products Partners's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,809,413,912
- Average return on equity (ROE) among peers: -22.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Calumet Specialty Products Partners (CLMT) | $-449.70 Million | -76.51% | N/A | $2.23 Billion |
| Albemarle Corp (ALB) | $4.47 Billion | 8.41% | 1.34x | $19.80 Billion |
| Alto Ingredients Inc (ALTO) | $119.26 Million | 2.58% | 0.95x | $212.84 Million |
| Aemetis Inc (AMTX) | $4.99 Million | -317.11% | 3.71x | $154.69 Million |
| Air Products and Chemicals Inc (APD) | $7.20 Billion | 13.81% | 1.48x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $2.17 Billion | 5.38% | 2.09x | $2.52 Billion |
| Avient Corp (AVNT) | $1.79 Billion | 12.89% | 1.79x | $3.16 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.96 Billion | 19.99% | 2.71x | $6.08 Billion |
| Balchem Corporation (BCPC) | $331.36 Million | 13.54% | 0.14x | $5.16 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $7.18 Million | 10.47% | 0.33x | $4.87 Million |
| Bon Natural Life Ltd (BON) | $44.35 Million | 0.90% | 0.39x | $7.30 Million |
About Calumet Specialty Products Partners
Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance Brands segments. The Specialty Products and Solutions segment offers various solvents, waxes, custo… Read more